Home
Resources
Product Analysis
Acknowledgements
About
Home
References
Business models
Business models
B2B
Products 51 to 60 of 162
Modify Display Properties
Biotech components
Business models
Country of production
Country of distribution
Intended consumer
Date added
Date last modified
Known funding amount
Funding types
Industry
Market status
Organization
Organization type(s)
Product categories
Production process
Source
Trading symbol
Value chain stage
Sort: Title (A-Z)
Date added (oldest-newest)
Date added (newest-oldest)
Date modified (oldest-newest)
Date modified (newest-oldest)
Title (A-Z)
Title (Z-A)
Organization (A-Z)
Organization (Z-A)
Cowless Milk
by
Perfect Day
Biotech components:
Animal
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Consumer
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
26,800,000 USD
Funding types:
Venture Capital
Industry:
Food & Agriculture
Market status:
Under Development
Organization type(s):
Private Company
Product categories:
Food
Production process:
Closed Production
Source:
NASEM Database
Trading symbol:
N/A
Value chain stage:
Input
CRISPR-Cas9
by
CRISPR
Biotech components:
Molecule
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
N/A
Intended consumer:
Research
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/11/08 13:59 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Science
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Research
Production process:
Closed Production
Source:
Web search
Trading symbol:
CRSP
(NASDAQ)
Value chain stage:
Finished Product
CRISPR/Cas9 Application in Poplar Trees
by
VIB (the Flanders Institute for Biotechnology)
Biotech components:
Gene Editing
Business models:
B2B
Country of production:
N/A
Country of distribution:
N/A
Intended consumer:
N/A
Date added:
2020/12/18 14:35 (4 years ago)
Date last modified:
2020/12/18 14:35 (4 years ago)
Known funding amount:
N/A
Funding types:
N/A
Industry:
Industrial
Market status:
Early Stage Concept
+
More information needed
Organization type(s):
Research Institution
Product categories:
Construction
+
Chemical
Production process:
N/A
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Input
+
Platform
CropOS
by
Benson Hill Biosystems
Biotech components:
Molecule
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
+
Spain
+
Brazil
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/06/21 16:07 (5 years ago)
Known funding amount:
34,700,000 USD
Funding types:
Venture Capital
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Research
Production process:
Closed Production
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Platform
D(-) Lactic Acid
by
GC Innovation America
+
Myriant
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
+
South East Asia
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/09/13 15:16 (6 years ago)
Known funding amount:
110,000,000 USD
Funding types:
Government
+
Venture Capital
Industry:
Industrial
Market status:
On the market
Organization type(s):
Private Company
Product categories:
Chemical
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
Danisco Xylanase
by
DuPont
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
Europe
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
2,147,483,647 USD
Funding types:
Shareholder Investment
Industry:
Food & Agriculture
Market status:
On the market
Organization type(s):
Public Company
Product categories:
Feed
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
DWDP
(NYSE)
Value chain stage:
Input
Deltazym® APS protease
by
BASF
Biotech components:
Molecule
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
USA
+
Canada
+
Switzerland
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2019/05/15 15:47 (6 years ago)
Known funding amount:
N/A
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
More information needed
+
No longer on the market
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Open Release
Source:
Web search
Trading symbol:
BAS
(ETR)
Value chain stage:
Input
Detalzym GA L-E5 Glucoamylase
by
BASF
+
Verenium
Biotech components:
Enzyme
Business models:
B2B
Country of production:
Switzerland
Country of distribution:
Germany
+
USA
+
China
+
Japan
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/12/26 15:16 (6 years ago)
Known funding amount:
2,147,483,647 EUR
Funding types:
Shareholder Investment
Industry:
Industrial
Market status:
No longer on the market
Organization type(s):
Public Company
Product categories:
Fuel and Energy
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
BAS
(ETR)
Value chain stage:
Input
Disease-Resistent Cacao Plant
by
Innovative Genomics Institute
Biotech components:
Plant
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/10/08 14:51 (6 years ago)
Known funding amount:
N/A
Funding types:
Private Funding
+
University
Industry:
Food & Agriculture
Market status:
Early Stage Concept
Organization type(s):
Research Institution
Product categories:
Plant
Production process:
Open Release
Source:
Web search
Trading symbol:
N/A
Value chain stage:
Finished Product
DNA Nanorobots
by
Wyss Institute
+
Harvard University
Biotech components:
Enzyme
Business models:
B2B
Country of production:
USA
Country of distribution:
USA
Intended consumer:
Commercial
Date added:
2018/08/30 11:49 (6 years ago)
Date last modified:
2018/08/30 11:49 (6 years ago)
Known funding amount:
37,000,000 USD
Funding types:
University
+
Government
Industry:
Health
Market status:
Early Stage Concept
Organization type(s):
Private Company
Product categories:
Medical Treatment
Production process:
Closed Production
Source:
SynBio Database
Trading symbol:
N/A
Value chain stage:
Input
1
2
3
4
5
6
7
8
9
10
…
17
Login
or
register
to add and edit products
Future
Bioengineered
Products
Home
Resources
Product Analysis
Acknowledgements
About
